FSV vs NSA

FSV demonstrates exceptional fundamental health with a Piotroski F-Score of 8/9, signaling strong operational efficiency and financial stability. However, the stock is trading at a significant premium, with a current price of $145.74 far exceeding both its Graham Number ($46.33) and Intrinsic Value ($93.52). While earnings growth is robust at 19.5% and analysts maintain a bullish target of $207, the technical trend is severely bearish (0/100) with a 20.5% decline over the last six months. The investment case currently rests on a conflict between high-quality internal health and an overextended valuation in a downward price trend.

NSA presents a high-risk profile characterized by a stable but mediocre Piotroski F-Score of 4/9 and a severe valuation disconnect. The stock is trading at $42.56, which is nearly 4x its Graham Number ($11.04) and double its Intrinsic Value ($20.35). Most critically, the dividend payout ratio of 330.43% indicates that the current yield is fundamentally unsustainable. While YoY growth metrics are strong, the combination of extreme valuation multiples and dangerously low liquidity (Current Ratio 0.16) outweighs the growth narrative.